New Insights into HIV-1 Persistence in Sanctuary Sites During Antiretroviral Therapy
New Insights into HIV-1 Persistence in Sanctuary Sites During Antiretroviral Therapy
Eva Poveda 1, Andrés Tabernilla 1
1 NULL
*Correspondence: Andrés Tabernilla, Email not available
Abstract
Current combinations of antiretroviral drugs for the treatment of HIV infection can successfully achieve and maintain long-term suppression of HIV-1 replication in plasma. Still, none of these therapies is capable of eradicating the virus from the long-lived cellular reservoir that represents the major barrier to HIV cure.
